U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519655) titled 'Phase 1 Study of PF-08046033 in Advanced Solid Tumors' on March 30.
Brief Summary: This is an early-stage (Phase 1) clinical study testing a new study medicine called PF-08046033. The goal of the study is to understand how safe the medicine is, how well people tolerate it, how it behaves in the body, and whether it shows early signs of helping to treat cancer.
The study includes adult participants who have advanced cancers that cannot be removed by surgery or have spread to other parts of the body. These cancers include non-small cell lung cancer, esophageal squamous cell cancer, and melanoma.
The study has two parts:
In the fir...